Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
This piece explains why index fund performance changes over time and what factors investors should monitor for better outcomes.
27,966 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Keller Williams announced an agreement to acquire the Jason Mitchell Group, marking a pivotal shift in the evolving b...
Qualcomm has vaulted from March lows as auto and IoT growth accelerates. Yet market skeptics linger, with hyperscaler...
A high-profile MEV attack on the jaredfromsubway.eth wallet coincides with Vitalik Buterin's push to curb these explo...
Citi boosts its Intel price target to $130, arguing a new CPU TAM framework driven by agentic AI workloads positions ...
Clive Davis, the legendary talent scout who built Arista and launched icons like Whitney Houston, has died at age 94,...
As market chatter heats up in 2026, investors are watching whether GE Vernova, MercadoLibre, or NVR will join the gro...
In morning trading, Tesla sinks about 5% while Lucid edges higher and Rivian drifts, signaling a diverging path for t...
SpaceX appoints a renowned Bitcoin miner to lead its first private crewed Mars mission. The development ties crypto w...
Nasdaq’s CFO argues that AI is a leadership issue, not a back-office project. With 650 institutions using its AI-powe...
Small-cap artificial intelligence stocks under $10 are rallying as enterprise AI demand grows, but investors face vol...
As AI-focused crypto assets roar, Pi Network faces a defining year. This report weighs whether will network (pi) outp...